Clinical Data Kainova expands DT 7012 trial into Europe PharmaTimesFirst patient dosed as DOMISOL study grows beyond AustraliaClinical DataOncologyRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) PharmaTimes First patient dosed as DOMISOL study grows beyond Australia Clinical DataOncologyRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Roche sticks with C4T, adding up to $1B for molecular glue partnershipNext: Innovent’s CDMO gets green light to make biologics at large Chinese plant Related Stories Clinical Data Boehringer advances duo for aggressive cancers into phase 3 pharminent June 22, 2026 Clinical Data Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short pharminent June 17, 2026 Clinical Data EHA26: BMS touts positive multiple myeloma data for two pipeline candidates pharminent June 17, 2026
